Canlyniadau Chwilio - Relecom, Allan

Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity gan Relecom, Allan, Merhi, Maysaloun, Inchakalody, Varghese, Uddin, Shahab, Rinchai, Darawan, Bedognetti, Davide, Dermime, Said

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Screening Status as a Determinant of Choice of Colorectal Cancer Screening Method: A Population-Based Informed Survey gan Sandoval, José Luis, Relecom, Allan, Ducros, Cyril, Bulliard, Jean-Luc, Arzel, Beatrice, Guessous, Idris

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy gan Raza, Afsheen, Merhi, Maysaloun, Inchakalody, Varghese Philipose, Krishnankutty, Roopesh, Relecom, Allan, Uddin, Shahab, Dermime, Said

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Resources-Stratified Guidelines for Classical Hodgkin Lymphoma gan Relecom, Allan, Federico, Massimo, Connors, Joseph M., Coiffier, Bertrand, Biasoli, Irene, Moccia, Alden, Salles, Gilles, McKee, Thomas, Miralbell, Raymond, Borchmann, Peter, Kuruvilla, John, Johnson, Peter, Cavalli, Franco, Delavy, Martine, Dietrich, Pierre-Yves, Flahault, Antoine

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Persistent anti-NY-ESO-1-specific T cells and expression of differential biomarkers in a patient with metastatic gastric cancer benefiting from combined radioimmunotherapy treatmen... gan Merhi, Maysaloun, Raza, Afsheen, Inchakalody, Varghese Philipose, Siveen, Kodappully S, Kumar, Deepak, Sahir, Fairooz, Mestiri, Sarra, Hydrose, Shereena, Allahverdi, Niloofar, Jalis, Munir, Relecom, Allan, Al Zaidan, Lobna, Hamid, Mohamed Sir Elkhatim, Mostafa, Mai, Gul, Abdul Rehman Zar, Uddin, Shahab, Al Homsi, Mohammed, Dermime, Said

Cael y testun llawn Cael y testun llawn Cael y testun llawn